Clinical Trial Update: Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab in combination with docetaxel and carboplatin for women with stage II or stage III breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Paraplatin (Carboplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Severance Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED